The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Several Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires
Abstract
The peptide binding specificities of HLA-DRB1*0401, DRB1*0101, and DRB1*0701 have been analyzed by the use of large collections of synthetic peptides corresponding to naturally occurring sequences. The results demonstrated that nearly all peptides binding to these DR molecules bear a motif characterized by a large aromatic or hydrophobic residue in position 1 (Y, F, W, L, I, V, M) and a small, noncharged residue in position 6 (S, T, C, A, P, V, I, L, M). In addition, allele-specific secondary effects and secondary anchors were defined, and these parameters were utilized to derive allele-specific motifs and algorithms. By the combined use of such algorithms, peptides capable of degenerate DRB1*0101, DRB1*0401, and DRB1*0701 binding were identified. Additional experiments utilizing a panel of quantitative assays specific for nine additional common DR molecules identified a large set of DR molecules, which includes at least the DRB1*0101, DRB1*0401, DRB1*0701, DRB5*0101, DRB1*1501, DRB1*0901, and DRB1*1302 allelic products, characterized by overlapping peptide-binding repertoires. These results have implications for understanding the molecular interactions involved in peptide-DR binding, as well as the genetic and structural basis of MHC polymorphism. These results also have potential practical implications for the development of epitope-based prophylactic and therapeutic vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450
Hepatitis B Virus Immunopathogenesis
Chisari, F. V. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.29 · Cited by 1,609
Lymphokine Production by Human T Cells in Disease States
Romagnani, S. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.227 · Cited by 1,343
The Regulation of Immunity to Leishmania major
Reiner, S. L. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.151 · Cited by 1,297
Sequence analysis of peptides bound to MHC class II molecules
Rudensky, A. Y., Preston-Hurlburt, P., Hong, S.-C., Barlow, A., & Janeway, C. A. (1991) · Nature · doi:10.1038/353622a0 · Cited by 1,075
Immunity to Intracellular Bacteria
Kaufmann, S. H. E. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001021 · Cited by 1,059
Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.
Chicz, R. M., Urban, R. G., Gorga, J. C., Vignali, D. A., Lane, W. S., & Strominger, J. L. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.1.27 · Cited by 887
Dominance and Crypticity of T Cell Antigenic Determinants
Sercarz, E. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.729 · Cited by 855
The Three-Dimensional Structure of Peptide-MHC Complexes
Madden, D. R. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.587 · Cited by 842
Chicz, R. M., Urban, R. G., Lane, W. S., Gorga, J. C., Stern, L. J., Vignali, D. A. A., & Strominger, J. L. (1992) · Nature · doi:10.1038/358764a0 · Cited by 768
Diepolder, H. M., Zachoval, R., Hoffmann, R. M., Jung, M.-C., Pape, G. R., Wierenga, E. A., Santantonio, T., & Eichenlaub, D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91691-1 · Cited by 687
Buus, S., Sette, A., Colon, S. M., Miles, C., & Grey, H. M. (1987) · Science · doi:10.1126/science.2435001 · Cited by 674
Self-citationHunt, D. F., Michel, H., Dickinson, T. A., Shabanowitz, J., Cox, A. L., Sakaguchi, K., Appella, E., Grey, H. M., & Sette, A. (1992) · Science · doi:10.1126/science.1319610 · Cited by 646
Self-citationProminent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules
Ruppert, J., Sidney, J., Celis, E., Kubo, R. T., Grey, H. M., & Sette, A. (1993) · Cell · doi:10.1016/0092-8674(93)90472-3 · Cited by 628
Self-citationA sequence pattern common to T cell epitopes.
Rothbard, J. B., & Taylor, W. R. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02787.x · Cited by 601
Structure of the p53 Tumor Suppressor Bound to the Ankyrin and SH3 Domains of 53BP2
Gorina, S., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.1001 · Cited by 571
Variability of hepatitis C virus
Simmonds, P. (1995) · Hepatology · doi:10.1002/hep.1840210243 · Cited by 567
Parkhurst, M. R., Salgaller, M. L., Southwood, S., Robbins, P. F., Sette, A., Rosenberg, S. A., & Kawakami, Y. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.6.2539 · Cited by 556
Self-citationAdjuvants — a balance between toxicity and adjuvanticity
Gupta, R. K., Relyveld, E. H., Lindblad, E. B., Bizzini, B., Ben-Efraim, S., & Gupta, C. K. (1993) · Vaccine · doi:10.1016/0264-410x(93)90190-9 · Cited by 545
Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., Robbins, P. F., Sette, A., Appella, E., & Rosenberg, S. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.3961 · Cited by 540
Self-citationAlexander, J., Sidney, J., Southwood, S., Ruppert, J., Oseroff, C., Maewal, A., Snoke, K., Serra, H. M., Kubo, R. T., Sette, A., et al. (1994) · Immunity · doi:10.1016/s1074-7613(94)80017-0 · Cited by 523
Self-citationVaccine design : the subunit and adjuvant approach
Powell, M. F., Newman, M. J., & Burdman, J. R. (1995) · Plenum Press eBooks · Cited by 451
Defining protective responses to pathogens: cytokine profiles in leprosy lesions
Yamamura, M., Uyemura, K., Deans, R., Weinberg, K., Rea, T., Bloom, B., & Modlin, R. (1991) · Science · doi:10.1126/science.254.5029.277 · Cited by 392
A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules
Sinigaglia, F., Guttinger, M., Kilgus, J., Doran, D. M., Matile, H., Etlinger, H., Trzeciak, A., Gillessen, D., & Pink, J. R. L. (1988) · Nature · doi:10.1038/336778a0 · Cited by 384
Promiscuous and allele-specific anchors in HLA-DR-binding peptides
Hammer, J., Valsasnini, P., Tolba, K., Bolin, D., Higelin, J., Takacs, B., & Sinigaglia, F. (1993) · Cell · doi:10.1016/0092-8674(93)90306-b · Cited by 376
Structures of an MHC Class II Molecule with Covalently Bound Single Peptides
Fremont, D. H., Hendrickson, W. A., Marrack, P., & Kappler, J. (1996) · Science · doi:10.1126/science.272.5264.1001 · Cited by 362
Vitiello, A., Ishioka, G., Grey, H. M., Rose, R., Farness, P., LaFond, R., Yuan, L., Chisari, F. V., Furze, J., & Bartholomeuz, R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117662 · Cited by 334
Self-citationWucherpfennig, K. W., Sette, A., Southwood, S., Oseroff, C., Matsui, M., Strominger, J. L., & Hafler, D. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.279 · Cited by 322
Self-citationSette, A., Buus, S., Appella, E., Smith, J. A., Chesnut, R., Miles, C., Colon, S. M., & Grey, H. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3296 · Cited by 310
Self-citationHammer, J., Bono, E., Gallazzi, F., Belunis, C., Nagy, Z., & Sinigaglia, F. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2353 · Cited by 290
Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity
Falo, L. D., Kovacsovics-Bankowski, M., Thompson, K., & Rock, K. L. (1995) · Nature Medicine · doi:10.1038/nm0795-649 · Cited by 289
Martin, R., Howell, M. D., Jaraquemada, D., Flerlage, M., Richert, J., Brostoff, S., Long, E. O., McFarlin, D. E., & McFarland, H. F. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.1.19 · Cited by 287
Current Status of Immunological Adjuvants
Warren, H. S., Vogel, F. R., & Chedid, L. A. (1986) · Annual Review of Immunology · doi:10.1146/annurev.iy.04.040186.002101 · Cited by 283
The Origins of HLA‐A,B,C Polymorphism
Parham, P., Adams, E. J., & Arnett, K. L. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00674.x · Cited by 264
Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs
Sidney, J., Grey, H. M., Kubo, R. T., & Sette, A. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80542-1 · Cited by 260
Self-citationTwo complementary methods for predicting peptides binding major histocompatibility complex molecules
Gulukota, K., Sidney, J., Sette, A., & DeLisi, C. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.0937 · Cited by 259
Self-citationMelanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes.
Topalian, S. L., Gonzales, M. I., Parkhurst, M., Li, Y. F., Southwood, S., Sette, A., Rosenberg, S. A., & Robbins, P. F. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.1965 · Cited by 257
Self-citationPeptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding.
Jardetzky, T. S., Gorga, J. C., Busch, R., Rothbard, J., Strominger, J. L., & Wiley, D. C. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08304.x · Cited by 247
O’Sullivan, D., Arrhenius, T., Sidney, J., Del Guercio, M. F., Albertson, M., Wall, M., Oseroff, C., Southwood, S., Colón, S. M., & Gaeta, F. C. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.8.2663 · Cited by 240
Self-citationFalk, K., R�tzschke, O., Stevanov�c, S., Jung, G., & Rammensee, H.-G. (1994) · Immunogenetics · doi:10.1007/bf00188785 · Cited by 228
Gorga, J. C., Horejsí, V, Johnson, D. R., Raghupathy, R., & Strominger, J. L. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47699-5 · Cited by 219
Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype.
del Guercio, M. F., Sidney, J., Hermanson, G., Perez, C., Grey, H. M., Kubo, R. T., & Sette, A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.2.685 · Cited by 205
Self-citationMechanism and Biological Significance of CD4‐mediated Cytotoxicity
HAHN, S., GEHRI, R., & ERB, P. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00684.x · Cited by 205
Valli, A., Sette, A., Kappos, L., Oseroff, C., Sidney, J., Miescher, G., Hochberger, M., Albert, E. D., & Adorini, L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116242 · Cited by 202
Self-citationNardin, E. H., & Nussenzweig, R. S. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.003351 · Cited by 197
Sidney, J., Grey, H. M., Southwood, S., Celis, E., Wentworth, P. A., del Guercio, M.-F., Kubo, R. T., Chesnut, R. W., & Sette, A. (1996) · Human Immunology · doi:10.1016/0198-8859(95)00173-5 · Cited by 195
Self-citationSeveral HLA alleles share overlapping peptide specificities.
Sidney, J., del Guercio, M. F., Southwood, S., Engelhard, V. H., Appella, E., Rammensee, H. G., Falk, K., Rötzschke, O., Takiguchi, M., Kubo, R. T., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.1.247 · Cited by 194
Self-citationvan der Most, R. G., Sette, A., Oseroff, C., Alexander, J., Murali-Krishna, K., Lau, L. L., Southwood, S., Sidney, J., Chesnut, R. W., Matloubian, M., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.12.5543 · Cited by 181
Self-citationMalaria vaccine development: a multi-immune response approach
Hoffman, S. L. (1996) · ASM Press eBooks · Cited by 180
Self-citationTsai, V, Southwood, S., Sidney, J., Sakaguchi, K., Kawakami, Y., Appella, E., Sette, A., & Celis, E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.4.1796 · Cited by 175
Self-citationStructural model of HLA-DR1 restricted T cell antigen recognition
Rothbard, J. B., Lechler, R. I., Howland, K., Bal, V., Eckels, D. D., Sekaly, R., Long, E. O., Taylor, W. R., & Lamb, J. R. (1988) · Cell · doi:10.1016/0092-8674(88)90464-3 · Cited by 172
Romani, L., Mencacci, A., Cenci, E., Spaccapelo, R., Mosci, P., Puccetti, P., & Bistoni, F. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.3.925 · Cited by 162
Functional Role for Syk Tyrosine Kinase in Natural Killer Cell–mediated Natural Cytotoxicity
Brumbaugh, K. M., Binstadt, B. A., Billadeau, D. D., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.1965 · Cited by 149
Sette, A., Sidney, J., Oseroff, C., del Guercio, M. F., Southwood, S., Arrhenius, T. S., Powell, M. F., Colon, S. M., Gaeta, F. C., & Grey, H. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.6.3163 · Cited by 148
Self-citationIn vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes
Reddy, R., Zhou, F., Nair, S. K., Huang, L., & Rouse, B. T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.5.1585 · Cited by 129
Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell Srfaces
Busch, R., Strang, G., Howland, K., & Rothbard, J. B. (1990) · International Immunology · doi:10.1093/intimm/2.5.443 · Cited by 125
Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401.
Hill, C. M., Liu, A., Marshall, K. W., Mayer, J. P., Jorgensen, B., Yuan, B., Cubbon, R. M., Nichols, E. A., Wicker, L. S., & Rothbard, J. B. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.6.2890 · Cited by 124
Hammer, J., Belunis, C. J., Bolin, D., Papadopoulos, J., Walsky, R. L., Higelin, J., Danho, W., Sinigaglia, F., & Nagy, Z. Á. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4456 · Cited by 121
Schmid, D. S. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.10.3610 · Cited by 108
Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules
Sidney, J., Southwood, S., del Guercio, M. F., Grey, H. M., Chesnut, R. W., Kubo, R. T., & Sette, A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3480 · Cited by 104
Self-citationMHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy
Topalian, S. L. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90078-7 · Cited by 100
Melief, C. J. M. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80081-1 · Cited by 98
Wang, R., Charoenvit, Y., Corradin, G., Vega, P. D. L., Franke, E. D., & Hoffman, S. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.9.4061 · Cited by 95
Self-citationD'Amaro, J., Houbiers, J. G. A., Drijfhout, J. W., Brandt, R. M. P., Schipper, R. F., Bavinck, J. N. B., Melief, C. J. M., & Kast, W. M. (1995) · Human Immunology · doi:10.1016/0198-8859(94)00153-h · Cited by 87
HLA-DR3 molecules can bind peptides carrying two alternative specific submotifs.
Geluk, A., van Meijgaarden, K. E., Southwood, S., Oseroff, C., Drijfhout, J. W., de Vries, R. R., Ottenhoff, T. H. M., & Sette, A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.12.5742 · Cited by 82
Self-citationRole of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands.
Marshall, K. W., Liu, A. F., Canales, J., Perahia, B., Jorgensen, B., Gantzos, R. D., Aguilar, B., Devaux, B., & Rothbard, J. B. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.4946 · Cited by 81
Attacking the infected hepatocyte.
Hoffman, S. L., Franke, E. D., Hollingdale, M. R., & Druilhe, P. (1996) · Cited by 78
Self-citationPrediction of peptide affinity to HLA DRB1*0401.
Marshall, K. W., Wilson, K. J., Liang, J., Woods, A., Zaller, D. M., & Rothbard, J. B. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.11.5927 · Cited by 74
Gamma interferon modifies CD4+ subset expression in murine candidiasis
Romani, L. R., Cenci, E., Mencacci, A., Spaccapelo, R., Grohmann, U., Puccetti, P., & Bistoni, F. (1992) · Infection and Immunity · doi:10.1128/iai.60.11.4950-4952.1992 · Cited by 66
New advances in vaccine delivery systems.
Eldridge, J. H., Staas, J. K., Chen, D., Marx, P. A., Tice, T. R., & Gilley, R. M. (1993) · PubMed · Cited by 58
GENETIC VARIABILITY OF THE HUMAN IMMUNODEFICIENCY VIRUS: Statistical and Biological Issues
Seillier‐Moiseiwitsch, F., Margolin, B. H., & Swanstrom, R. I. (1994) · Annual Review of Genetics · doi:10.1146/annurev.ge.28.120194.003015 · Cited by 51
Kofler, N., Ruedl, C., Klima, J., Recheis, H., Böck, G., Wick, G., & Wolf, H. (1996) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)00267-7 · Cited by 21
Chesnut, R. W., Sette, A., Celis, E., Wentworth, P. A., Kubo, R. T., Alexander, J., Ishioka, G. Y., Vitiello, A., & Grey, H. M. (1995) · Pharmaceutical biotechnology · doi:10.1007/978-1-4615-1823-5_38 · Cited by 20
Self-citation
Cited by
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
Self-citationCancer vaccines as promising immuno-therapeutics: platforms and current progress
Liu, J., Fu, M., Wang, M., Wan, D., Wei, Y., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01247-x · Cited by 715
Hill, J. A., Southwood, S., Sette, A., Jevnikar, A. M., Bell, D. A., & Cairns, E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.538 · Cited by 713
Self-citationTumor antigen-specific T helper cells in cancer immunity and immunotherapy
Knutson, K. L., & Disis, M. L. (2005) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-004-0653-2 · Cited by 682
Metadata
- Authors
- Southwood, S., Sidney, J., Kondo, A., del Guercio, M.-F., Appella, E., Hoffman, S., Kubo, R. T., Chesnut, R. W., Grey, H. M., & Sette, A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-04-01
- Volume
- 160
- Issue
- 7
- Pages
- 3363-3373
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1944657476
- Cited by
- 665
- References
- 73
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.